Search results for "Lua"

showing 10 items of 3286 documents

TCP Performance in Mobile Ad hoc Networks

2013

International audience; In this paper, we present a survey of TCP (Transmission Control Protocol) protocol for better performance in the MANET (Mobile Ad Hoc Network). After a short presentation of the main features of TCP, we give the most important problems from which TCP suffer in MANET. We present after that some approaches proposed in the literature in order to improve its performance. Our paper contains also a performance evaluation of TCP NewReno and TCP Vegas transport protocols under AODV and DSR routing protocols. The simulations are conducted under varying conditions of number of TCP connections, number of nodes and mobility.

CUBIC TCPTCP accelerationComputer scienceTCP tuning050801 communication & media studies02 engineering and technologyTCP Friendly Rate ControlTCP Westwood[INFO.INFO-NI]Computer Science [cs]/Networking and Internet Architecture [cs.NI]0508 media and communications0202 electrical engineering electronic engineering information engineeringZeta-TCPMobile Ad hoc NetworksProblems of TCP in MANETTCP Protocolbusiness.industry05 social sciencesComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSImproving of TCP in MANET020206 networking & telecommunicationsINGENIERIA TELEMATICATCP VegasTCP global synchronizationPerformance evaluationTCP NewRenoCompound TCPbusinessComputer network
researchProduct

BOTANICAL CONTRIBUTION TO ARCHAEOLOGICAL LAND EVALUATION IN THE FP7 MEMOLA PROJECT

2014

CULTURAL LANDSCAPE HERITAGE LANDSCAPE ARCHAEOLOGY TRADITIONAL PEASANT KNOWLEDGE ECOSYSTEM SERVICE LAND USE EVALUATION SOIL WATER ENVIRONMENT SUSTAINABILITY MEDITERRANEAN MOUNTAIN AGROSYSTEMSettore BIO/03 - Botanica Ambientale E Applicata
researchProduct

Comisión de Test: veinticinco años velando por la calidad de los test

2022

[ES]El objetivo del presente trabajo es mostrar las actividades y proyectos llevados a cabo por la Comisión de Test del Consejo General de Psicología de España para mejorar la calidad y el uso de los test. Se repasan los proyectos más relevantes de la comisión durante sus veinticinco años de existencia, describiendo los trabajos llevados a cabo para a) conocer las opiniones y actitudes de los psicólogos hacia los test, b) evaluar la calidad de los test editados en España, y c) desarrollar estándares, directrices y códigos éticos y deontológicos que mejoren la práctica de los test. También se resaltan otras actividades de la comisión de carácter formativo, así como sus relaciones con otras o…

Calidad de los testpsicometríaTesttestEvaluacióncalidad de los testUso adecuado de los testuso adecuado de los testPsicometríaevaluaciónGeneral Psychology
researchProduct

Revisión del modelo para evaluar la calidad de los tests utilizados en España

2016

Para usar adecuadamente los tests, es necesario que los profesionales cuenten con información rigurosa de su calidad. Es por ello que, desde hace unos años, se viene aplicando el modelo español de evaluación de la calidad de los tests (Prieto y Muñiz, 2000). El objetivo de este trabajo es actualizar y revisar dicho modelo, con el fin de incorporar las recomendaciones hechas en sus aplicaciones, y para incorporar los avances psicométricos y tecnológicos que se han producido durante los últimos años. El modelo original fue revisado en varias fases, y la revisión originalmente propuesta fue revisada por un conjunto de expertos, lo que dio lugar a la versión final que se describe en este trabaj…

Calidad de los tests.lcsh:PsychologyUso de testslcsh:BF1-990modelos de evaluacióncalidad de los testsModelos de evaluaciónPsicología
researchProduct

Calidad de vida : evaluación y trastornos del espectro del autismo

2013

espanolEn este articulo se muestran las conclusiones de la investigacion "senda hacia la participacion", desarrollada por la Asociacion Autismo Burgos, analizando los resultados de la aplicacion de cuatro instrumentos para evaluar la calidad de vida en una muestra de veinticuatro personas con Trastorno del Espectro del Autismo (tea). Los resultados obtenidos reflejan las dificultades de estos instrumentos para medir la calidad de vida de las personas con tea, limitaciones que nos llevan a construir una guia de indicadores de calidad de vida, en colaboracion con los padres de la Asociacion. La guia se realizo a traves de un grupo focal del que participaron trece padres, dirigido por dos prof…

Calidad de vidaTestsGeneral MedicineautismoevaluaciónDiscapacidad intelectuallcsh:Education (General)bienestarcalidad de vida; trastornos del espectro del autismo; trastorno autístico; evaluación de la discapacidad; participación comunitaria; relaciones profesional-familiaconducta socialTrastornos del espectro autistaDiscapacidad del lenguajeAutismeEfectosMediciónlcsh:L7-991
researchProduct

Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole …

2019

Heterocyclic rings are recognized as key components of many natural, semi-synthetic and synthetic molecules with a broad spectrum of biological activities. Among these molecules, the indole and imidazo[2,1-b][1,3,4]thiadiazole systems have recently been described as useful scaffolds for the design of anticancer agents. Herein the antitumor activity of a series of 3-(6-phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indoles, designed as hybrid structures, was assessed. Seven out of 10 compounds (1a-g) were submitted to National Cancer Institute (NCI). Remarkably, compound 1g showed antiproliferative activity against the full panel of sixty human cancer lines, with half-maximal inhibitory conc…

Cancer Research3Stereochemistry1-b][1Indole systemAntineoplastic Agent03 medical and health sciences0302 clinical medicine4]thiadiazole derivativeCell MovementCell Line TumorPancreatic cancermedicineImidazo[2Cell ProliferationBiological evaluationAntitumor activityIndole testChemistryCancerAnti-migratory activityPancreatic cancerGeneral Medicinemedicine.diseaseIn vitroPancreatic NeoplasmsOncologyIndolePancreatic cancer cell030220 oncology & carcinogenesisAnti-proliferative activityHuman cancerHuman
researchProduct

Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside

2014

Cancer is a disease caused by DNA mutations. Cancer therapies targeting defined functional mutations have shown clinical benefit. However, as 95% of the mutations in a tumour are unique to that single patient and only a small number of mutations are shared between patients, the addressed medical need is modest. A rapidly determined patient-specific tumour mutation pattern combined with a flexible mutation-targeting drug platform could generate a mutation-targeting individualised therapy, which would benefit each single patient. Next-generation sequencing enables the rapid identification of somatic mutations in individual tumours (the mutanome). Immunoinformatics enables predictions of mutat…

Cancer ResearchMutationbusiness.industryGenetic enhancementDrug Evaluation PreclinicalCancerGenomicsmedicine.diseasePrecision medicinemedicine.disease_causeBioinformaticsCancer VaccinesTranslational Research BiomedicalBreast cancerOncologyImmunologyMutationMedicineHumansPersonalized medicineCancer vaccineMinireviewRNA NeoplasmPrecision MedicinebusinessBritish Journal of Cancer
researchProduct

Analyse économique des essais cliniques internationaux en cancérologie

2018

International audience; In oncology, as in other fields of medicine, international multicentre clinical trials came into being so as to include a sufficient number of subjects to investigate a clinical situation. The existence of tight budgetary constraints and the desire to make the best use of the resources available have resulted in the development of economic evaluations associated with these trials, which, thanks to their level of evidence and their size, provide particularly relevant material. Nonetheless, economic evaluations alongside international clinical trials raise specific questions of methodology with regard to both the design and the analysis of the results. Indeed, the cost…

Cancer ResearchMéthodologie[SDV.CAN]Life Sciences [q-bio]/Cancer[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciencesEssai clinique international0302 clinical medicineGoods and services[SDV.CAN] Life Sciences [q-bio]/CancerMonetary valueInternational clinical trialMethodsRadiology Nuclear Medicine and imaging030212 general & internal medicineBudget constraintComputingMilieux_MISCELLANEOUSIndividual countryÉvaluation économique.Public economics030503 health policy & services[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieHematologyGeneral MedicineEvidence-based medicineEconomic evaluation3. Good healthClinical trialEconomic dataOncologyWork (electrical)[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieBusiness0305 other medical science
researchProduct

Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice

2003

Abstract Purpose The effect of recombinant human erythropoietin (rhEPO) on the radiosensitivity of human tumor xenografts growing in anemic and nonanemic nude mice was studied. Methods and materials Anemia was induced by total body irradiation ([TBI], 2 × 4 Gy) of mice before tumor implantation into the subcutis of the hind leg. The development of anemia was prevented by rhEPO (750 U/kg s.c.) given 3 times weekly starting 2 weeks before TBI. Fourteen days after fractionated TBI (tumor volume of approx. 40 mm 3 ), single-dose irradiation of the tumor with varying doses was performed so that in full dose–response relationship for the probability of tumor cure was obtained. Results Radiation-i…

Cancer ResearchPathologymedicine.medical_specialtyAnemiamedicine.medical_treatmentTransplantation HeterologousDrug Evaluation PreclinicalUrologyMice NudeHindlimbRadiation ToleranceHemoglobinsMicemedicineAnimalsHumansRadiology Nuclear Medicine and imagingRadiosensitivityddc:610ErythropoietinRadiationbusiness.industryAnemiaSarcomaHypoxia (medical)Total body irradiationmedicine.diseaseCell HypoxiaRecombinant ProteinsRadiation therapyRadiation Injuries ExperimentalOncologyErythropoietinDose Fractionation RadiationHemoglobinmedicine.symptombusinessNeoplasm TransplantationWhole-Body Irradiationmedicine.drug
researchProduct

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

2003

Neuroblastoma is the second most frequent malignancy in childhood. We investigated whether screening for neuroblastoma at 1 year of age reduces the incidence of metastatic disease or mortality. Screening was offered in 6 of the 16 German states from 1995 to 2000 with the remaining states serving as controls. We studied 2,581,188 children in the screening area born between 1994 and 1999 and 2,117,600 in the control area. We compared mortality from neuroblastoma and the incidence of disseminated disease in the two groups. The screened group and the control group had similar rates of stage 4 neuroblastoma and mortality due to neuroblastoma. Comparison of the screened group and the control area…

Cancer ResearchPediatricsmedicine.medical_specialtyPopulationCohort StudiesNeuroblastomaPredictive Value of TestsGermanyNeuroblastomaEpidemiologyHumansMass ScreeningMedicineOverdiagnosiseducationFalse Negative ReactionsMass screeningNeoplasm Stagingeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Infantmedicine.diseaseOncologyScreening for NeuroblastomaChild PreschoolPopulation SurveillancebusinessProgram EvaluationCohort studyCancer Letters
researchProduct